Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.65
Share price
0.00%
Change (1 day)
8.98%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ4.62 Billion

According to Catalent's latest financial reports the company's total liabilities are ยฃ4.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30ยฃ4.85 B2.89%
2022-06-30ยฃ4.71 B34.76%
2021-06-30ยฃ3.49 B1.48%
2020-06-30ยฃ3.44 B12.33%
2019-06-30ยฃ3.06 B17.69%
2018-06-30ยฃ2.60 B24.21%
2017-06-30ยฃ2.09 B13.97%
2016-06-30ยฃ1.84 B15.39%
2015-06-30ยฃ1.59 B-21.1%
2014-06-30ยฃ2.02 B-8.43%
2013-06-30ยฃ2.20 B-0.66%
2012-06-30ยฃ2.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ0.27 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.40 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ5.55 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.24 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA